Verification of drug license & valid prescription is strongly advised for the users before dealing in medicines

Rabeprazole Sodium and Domperidone Capsules

₹ 900/Box

Strength20 mg+30 mg
Drug CompositionRabeprazole 20mg and Domperidone 30mg
Release TypeSR
Strip Pack Size10 capsules
Packaging TypeBox
Brand NameRebkrish-DSR
ManufacturerKrishgir Pharmaceuticals Private Limited
CompositionRabeprazole Sodium and Domperidone
FormCapsules
Packing Size10x10 Capsules
TreatmentNausea, Vomiting Reducer
AvailabilityIn Stock
View in Hindi राबेप्राजोल सोडियम और डॉम्पेरिडोन कैप्सूल
RABEPRAZOLE SODIUM+DOMPERIDONE is used to treat acidity, heartburn, gastro-oesophageal reflux disease (GERD), Zollinger-Ellison syndrome, nausea, vomiting, the fullness of the stomach, bloating, gas, helicobacter pylori infection, gastric and duodenal ulcers.

Find products similar to Rabeprazole Sodium And Domperidone Capsules

Find related categories

Shipping Information

PriceExcluding all taxes
Ships fromPanchkula
ShippingAs per delivery location

Product Image

Rabeprazole Sodium and Domperidone Capsules-1Rabeprazole Sodium and Domperidone Capsules-2

About the Company

GST Registration Date
Mar 2020
Legal Status of Firm
Limited Company
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
Upto 10 People
Annual Turnover
5 - 25 Cr
IndiaMART Member Since
Mar 2022
GST
06**********1Z3

Established in year 2010 , We “Krishgir Pharmaceuticals Private Limited.” are Manufacture , Service Provider of an Pharmaceutical Tablets, Pharmaceutical Capsules, Tablets ,Pharmaceutical Injection etc . We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers.


For our accomplishment story, we are grateful to our Mrs Kiran Kumari whose continual backing and direction have been useful to us for attaining exponential development in the current market.